A Randomized Trial of Low Versus Moderate Exposure Busulfan for Infants with Severe Combined Immunodeficiency (SCID) Receiving TCRaß+/CD19+ Depleted Transplantation: A Phase II Study by the Primary Immune Deficiency Treatment Consortium (PIDTC) and Pediatric Blood and Marrow Transplant Consortium (PBMTC) PIDTC “CSIDE” Protocol (Conditioning SCID Infants Diagnosed Early) PBMTC NMD 1801

Grant

Date/time Interval

  • December 1, 2019 - November 30, 2023
  • Total Award Amount

  • 3000.00
  • Direct Costs

  • 2307.00
  • Sponsor Award Id

  • Contributor

  • Antonio Di Stasi M.D.   Investigator  
  • Frederick Goldman M.D.   Principal Investigator  
  • Hilary Haines   Investigator  
  • Joseph Chewning III M.D.   Investigator